[Multicenter randomized controlled study of temozolomide versus semustine in the treatment of recurrent malignant glioma].
Sun J, Yang XJ, Yang SY.
Zhonghua Yi Xue Za Zhi · multicenter study; randomized controlled trial; journal article PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för semustine. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
18 hitsMutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O(6)-methylguanine DNA-methyltransferase.
Wang X, Chen JX, Liu YH, You C, Mao Q.
Neurol Sci · journal article · DOI 10.1007/s10072-012-1257-9Anticancer agents for treatment of tumors in the central nervous system by correspondent substituent substitution and elucidation by pattern recognition methods.
Bartzatt R.
Med Chem · research support, non-u.s. gov't; journal article · DOI 10.2174/157340612800493557[Comparison of two regimens of postoperative concurrent chemoradiotherapy in adult patients with grade III-IV cerebral gliomas].
Zhai X, Wang J, Zhang J, Gu K.
Nan Fang Yi Ke Da Xue Xue Bao · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal articleCandidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z, Liu Y, He H, Chen X, Chen J, Lu YC.
Brain Res Bull · research support, non-u.s. gov't; journal article · DOI 10.1016/j.brainresbull.2011.07.010Quantification of meCCNU-induced dG-dC crosslinks in oligonucleotide duplexes by liquid chromatography/electrospray ionization tandem mass spectrometry.
Bai B, Zhao L, Zhong R.
Rapid Commun Mass Spectrom · research support, non-u.s. gov't; journal article · DOI 10.1002/rcm.5064A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.
Ma X, Guo Y, Pang Z, Wang B, Lu H, Gu YJ, Guo X.
Radiother Oncol · clinical trial, phase ii; randomized controlled trial; journal article · DOI 10.1016/j.radonc.2009.08.045[Microsurgical strategies of glioma located in lateral fissure area].
Chen JX, Lu YC, Wang CL, Sun KH, Ding XH, Hu GH, Luo C, Lou MQ, Xu T, Wu XJ, Chen XX.
Zhonghua Yi Xue Za Zhi · research support, non-u.s. gov't; journal article; english abstractPulmonary fibrosis associated with low-dose adjuvant methyl-CCNU.
Block M, Lachowiez RM, Rios C, Hirschl S.
Med Pediatr Oncol · journal article; case reports · DOI 10.1002/mpo.2950180320Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect.
Boice JD, Greene MH, Killen JY, Ellenberg SS, Fraumeni JF, Keehn RJ, McFadden E, Chen TT, Stablein D.
N Engl J Med · letter · DOI 10.1056/nejm198601093140214Acute leukemia after adjuvant therapy of gastrointestinal cancer with semustine (methyl-CCNU)
Författaruppgift saknas
N Engl J Med · letter · DOI 10.1056/nejm198404193101615Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).
Boice JD, Greene MH, Killen JY, Ellenberg SS, Keehn RJ, McFadden E, Chen TT, Fraumeni JF.
N Engl J Med · clinical trial; randomized controlled trial; journal article · DOI 10.1056/nejm198311033091802Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N, Yagoda A, Braun D.
Cancer · comparative study; clinical trial; research support, u.s. gov't, p.h.s.; randomized controlled trial; journal article · DOI 10.1002/1097-0142(19830101)51:1<20::aid-cncr2820510106>3.0.co;2-dCase report: acute leukemia after semustine (methyl-CCNU) therapy.
Uphouse WJ, Oishi N.
Cancer Treat Rep · letter; case reportsPhase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
Creagan ET, Ahmann DL, Schutt AJ, Green SJ.
Cancer Treat Rep · journal articleNephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy.
Micetich KC, Jensen-Akula M, Mandard JC, Fisher RI.
Am J Med · clinical trial; journal article · DOI 10.1016/0002-9343(81)90315-6Response of metastatic cloacogenic carcinoma to treatment with semustine.
Zimm S, Wampler GL.
Cancer · journal article; case reports · DOI 10.1002/1097-0142(19811215)48:12<2569::aid-cncr2820481206>3.0.co;2-xMethyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Posey LE, Morgan LR.
Cancer Treat Rep · comparative study; clinical trial; research support, u.s. gov't, p.h.s.; randomized controlled trial; journal article